🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial will investigate the pharmacokinetics, safety and tolerability o...
Status
Completed
Location
1297.1.002 Boehringer Ingelheim Investigational Site
Start Date
2011-12-01
Trial ID
NCT01505491
Treatments Being Tested
This healthy volunteers study will evaluate 210 subjects who will receive a...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-05
Trial ID
NCT01870986
Treatments Being Tested
Investigate the pharmacokinetics, safety and tolerability of SCT630 and to ...
Status
Completed
Location
Beijing SHIJITAN Hospital
Start Date
2019-05-29
Trial ID
NCT03917628
Treatments Being Tested
The primary objective of this study is to evaluate candidate predictors of ...
Status
Completed
Location
Research Site
Start Date
2019-06-30
Trial ID
NCT04089514
Treatments Being Tested
Safety and Efficacy study of AVT02 (Alvotech Biosimilar to Adalimumab), in ...
Status
Completed
Location
Innomedica OU
Start Date
2019-02-20
Trial ID
NCT03849404
Treatments Being Tested
The main objective of this study is to evaluate the safety of adalimumab in...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00775437
Treatments Being Tested
The purpose of this study is to compare the efficacy, safety and immunogeni...
Status
Completed
Location
MHAT "Trimontium", OOD
Start Date
2017-01-31
Trial ID
NCT03052322
This is a randomized, double-blind, two-arm, parallel group, single-dose st...
Status
Completed
Location
PAREXEL International GmbH, Early Phase Clinical Unit Berlin
Start Date
2019-07-17
Trial ID
NCT04439929
Treatments Being Tested
This is a Phase 1, double blind (sponsor open), randomized (1:1:1), paralle...
Status
Completed
Location
De La Pedraja Radiology Associates
Start Date
2014-09
Trial ID
NCT02237729
Treatments Being Tested
This is a Phase 3 Study to Compare Pharmacokinetics, Efficacy and Safety of...
Status
Completed
Location
CT-P17 3.3 investigational site
Start Date
2022-11-07
Trial ID
NCT05495568
Treatments Being Tested